Hiroshi Kagamu

Saitama, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 197 publications

Correction: Immunological impact of tumor-draining lymph node dissection on systemic Th1-like CD4+ T cells in patients with early-stage lung cancer.

Correction: Immunological impact of tumor-draining lymph node dissection on systemic Th1-like CD4+ T cells in patients with early-stage lung cancer.

Journal: Cancer immunology, immunotherapy : CII

Published: August 01, 2026

A Case of Tumor Embolism to the Lower Extremity Artery Caused by Pulmonary Sarcoma With Left Atrial Invasion.

A Case of Tumor Embolism to the Lower Extremity Artery Caused by Pulmonary Sarcoma With Left Atrial Invasion.

Journal: Clinical case reports

Published: May 18, 2026

Immunological impact of tumor-draining lymph node dissection on systemic Th1-like CD4+ T cells in patients with early-stage lung cancer.

Immunological impact of tumor-draining lymph node dissection on systemic Th1-like CD4+ T cells in patients with early-stage lung cancer.

Journal: Cancer immunology, immunotherapy : CII

Published: January 31, 2026

Synchronous occurrence of interstitial lung disease and ICANS after tarlatamab initiation in recurrent small-cell lung cancer.

Synchronous occurrence of interstitial lung disease and ICANS after tarlatamab initiation in recurrent small-cell lung cancer.

Journal: Respiratory medicine case reports

Published: January 24, 2026

Tumor-Derived Extracellular Vesicles in Plasma for Predicting Anti-PD-1 Antibody Efficacy in Non-Small Cell Lung Cancer.

Tumor-Derived Extracellular Vesicles in Plasma for Predicting Anti-PD-1 Antibody Efficacy in Non-Small Cell Lung Cancer.

Journal: Cancer science

Published: January 20, 2026

Real-world occurrence of severe gastrointestinal bleeding in patients receiving amivantamab plus lazertinib: A two-case series among 25 consecutive cases.

Real-world occurrence of severe gastrointestinal bleeding in patients receiving amivantamab plus lazertinib: A two-case series among 25 consecutive cases.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: January 19, 2026

The impact of local tumor immune responses on prognosis in resected lung adenocarcinoma.

The impact of local tumor immune responses on prognosis in resected lung adenocarcinoma.

Journal: Translational lung cancer research

Published: January 11, 2026

Concurrent Chemoradiotherapy with Daily Low-Dose Carboplatin in Older Patients with Unresectable Locally Advanced Non-Small-Cell Lung Cancer: Clinical Outcomes and Prognostic Significance of Systemic Inflammation Markers.

Concurrent Chemoradiotherapy with Daily Low-Dose Carboplatin in Older Patients with Unresectable Locally Advanced Non-Small-Cell Lung Cancer: Clinical Outcomes and Prognostic Significance of Systemic Inflammation Markers.

Journal: Current oncology (Toronto, Ont.)

Published: January 07, 2026

TROP2 expression as a prognostic predictor for osimertinib in patients with EGFR-mutant non-small cell lung cancer.

TROP2 expression as a prognostic predictor for osimertinib in patients with EGFR-mutant non-small cell lung cancer.

Journal: Translational lung cancer research

Published: December 28, 2025

Sequential Immune Activation of Effector T Cells as Biomarkers of Response to Durvalumab in Patients with Locally Advanced NSCLC.

Sequential Immune Activation of Effector T Cells as Biomarkers of Response to Durvalumab in Patients with Locally Advanced NSCLC.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: November 21, 2025

Early FMISO PET changes as exploratory predictors of immune checkpoint inhibitor response in advanced lung cancer: a pilot study.

Early FMISO PET changes as exploratory predictors of immune checkpoint inhibitor response in advanced lung cancer: a pilot study.

Journal: Scientific reports

Published: November 05, 2025

G-CSF-producing pulmonary sarcomatoid carcinoma treated with chemoradiotherapy followed by durvalumab: a case report.

G-CSF-producing pulmonary sarcomatoid carcinoma treated with chemoradiotherapy followed by durvalumab: a case report.

Journal: Respiratory medicine case reports

Published: October 20, 2025

Showing 1-12 of 197

Last Updated: 09/26/2026